Frataxin-mediated PINK1-parkin-dependent mitophagy in hepatic steatosis: the protective effects of quercetin
There is limited information on the molecular mechanisms involving antioxidants in treating psychiatric disorders
"I was willing to take the risk because of how unhappy I was." Weinstein shared that she was on the medication for two or three months, where she experienced weight loss and more "side effects that didn't make [her] feel like [herself] or happy." She added, "I was the first one, a year ago, to judge
After applying eligibility criteriaincluding documented weight reduction within one year prior to fertility treatment, no history of bariatric surgery or prior pregnancy, complete BMI data and no use of other anti-obesity medications (liraglutide, exenatide, dulaglutide, orlistat)eligible patients were stratified into three BMI categories: overweight (25.029.9 kg/m), obese class I (30.034.9 kg/m), and obese class IIIII ( 35.0 kg/m)